Results 161 to 170 of about 38,779 (193)

Exceeding expectations: factors contributing to the potency of human papillomavirus vaccines. [PDF]

open access: yesLancet Microbe
Schiller JT   +5 more
europepmc   +1 more source

HPV Exposure in the Gynecological Practice: Time to Call It an Occupational Disease? A Systematic Review of the Literature and ESGO Experts' Opinion. [PDF]

open access: yesVaccines (Basel)
Ege HV   +10 more
europepmc   +1 more source

Development of a 12-Valent HPV L1 Virus-like Particle Vaccine Using an Enhanced Baculovirus Expression System. [PDF]

open access: yesVaccines (Basel)
Kim JD   +10 more
europepmc   +1 more source

Analysis of Tumorigenesis in Human Papillomavirus Transgenic Mouse

open access: yesAnalysis of Tumorigenesis in Human Papillomavirus Transgenic Mouse
openaire  

Novel Laboratory Mouse Papillomavirus (MusPV) Infection

Veterinary Pathology, 2010
Most papillomaviruses (PVs) are oncogenic. There are at least 100 different human PVs and 65 nonhuman vertebrate hosts, including wild rodents, which have species–specific PV infections. Florid papillomatosis arose in a colony of NMRI- Foxn1 nu /Foxn1 nu
Ingle, A   +5 more
openaire   +2 more sources

Genomic analysis of the first laboratory-mouse papillomavirus

Journal of General Virology, 2010
A papillomavirus (PV) that naturally infects laboratory mice will provide an extremely valuable tool for PV research. We describe here the isolation, cloning and molecular analysis of the first novel laboratory-mouse PV, designated MusPV. This agent, recently identified in the tissues from florid and asymmetrical papillomas on the face of nude mice ...
Joh, J   +6 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy